Dan Ohayon

Entrepreneur | 2x Exit | Business Angel | Strategic Advisor | Tech & DeepTech | | | | | - France - Israel

📍 France🔄 Updated September 2026💼 6 investments📅 6 years investing🗓 Last invested Jan 2026
VC🌍 FranceInvested this year
6
Total investments
0
Early stage
3
Mid stage
2
Late stage
6y
Years active

Portfolio

5 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Private Investor
Jan 2024
Plas-Free is a clinical-stage medical device company developing an advanced filtration technology for blood purification with the aim to save lives and reduce healthcare costs. Plas-Free’s upcoming products provide a simple yet revolutionary approach to advance critical care that address clear unmet needs: 1. ClearPlasma for use during massive internal bleeding modifies human plasma to enhance coagulation and hemostasis, effectively reducing bleeding by 55% in clinical studies. 2. AAPC-300 for use in HyperAmmonia in liver malfunctions, removes ammonia from the blood stream, effectively extracting > 80% of the ammonia in clinical studies. Plas-Free operates as part of a portfolio company of NGT3VC Healthcare venture capital fund. The company is active both in Israel and the US (PA). To learn more, visit www.plas-free.com or follow us on Linkedin.
Private Investor
Jul 2023
Lanalyse dimages de vidéo-surveillance par Intelligence Artificielle
Private Investor
May 2023
So Shape is one of the fastest growing food-tech companies in Europe. Just launched in the US! So Shape creates smarter food alternatives to finally solve weight related problems for everyone, in real life. As of now, the company has launched 2 successful brands: The So Shape Challenge, an innovative meal-replacement-based kit for a safer express weight loss experience. More than 300 000 customers and followers. BRKFST, a new range of healthy comfort foods to fix the traditional high-sugar, low nutritious breakfasts. Stay tuned for more innovations! 🚀
Private Investor - CFO
Apr 2023
PALTech is a MedTech project aiming at treating Type 2 diabetes. The project is led by 2 scientists: - Dr. Reginald Allouche: a renowned diabetologist who has been working on this disease for many years - Pr. Charles-Henri Malbert: MD and DMV, pHD, Senior Research Director, head of Aniscan research Unit (Rennes, France), Adjunct Professor of Medicine University of Adelaide, Full Member of National Medicine Academy
SVP / Investor
Aug 2020
Molotov is a streaming platform that is revolutionizing access to television and content, available on all screens and connected devices (TechCrunch). Molotov offers an unprecedented experience combining, in a single interface, linear and non-linear programs from nearly 200 publishers and television channels. Founded by JeanDavid Blanc (tech veteran also founder of AlloCiné) and Pierre Lescure (co-founder of Canal+), Molotov is part of fuboTV, the worlds leading sports-first live TV streaming platform, since December 2021. Selected in the French Tech 120 government index, among the 10 Top LinkedIn Start-ups 2020, and awarded four times "Best application of the year by users of the App Store (Apple), Google Play (Android) and by AppAnnie, Molotov has, after 5 years of existence, more than 19 million users, thus becoming the French leader in the distribution of streaming programs.
mid stageEntertainment
Experience · 8 entries
All (8)
Investments (5)
Founder (3)
2026
Private Investor - Cofounder & CFO
Jan 2026
Let it Cast opens up the casting process by enabling productions to audition actors online through video. Leading service for video and international casting for productions directed by Darren Aronofsky, Glenn Casale, Larry Clark, Costa-Gavras, Curtis Hanson, Werner Herzog, Joseph Kosinski, Isild Le Besco, Max Makowsky, Paul Schrader…
2024
Private Investor
Jan 2024
Plas-Free is a clinical-stage medical device company developing an advanced filtration technology for blood purification with the aim to save lives and reduce healthcare costs. Plas-Free’s upcoming products provide a simple yet revolutionary approach to advance critical care that address clear unmet needs: 1. ClearPlasma for use during massive internal bleeding modifies human plasma to enhance coagulation and hemostasis, effectively reducing bleeding by 55% in clinical studies. 2. AAPC-300 for use in HyperAmmonia in liver malfunctions, removes ammonia from the blood stream, effectively extracting > 80% of the ammonia in clinical studies. Plas-Free operates as part of a portfolio company of NGT3VC Healthcare venture capital fund. The company is active both in Israel and the US (PA). To learn more, visit www.plas-free.com or follow us on Linkedin.
2023
Private Investor
Jul 2023
Lanalyse dimages de vidéo-surveillance par Intelligence Artificielle
Private Investor
May 2023
So Shape is one of the fastest growing food-tech companies in Europe. Just launched in the US! So Shape creates smarter food alternatives to finally solve weight related problems for everyone, in real life. As of now, the company has launched 2 successful brands: The So Shape Challenge, an innovative meal-replacement-based kit for a safer express weight loss experience. More than 300 000 customers and followers. BRKFST, a new range of healthy comfort foods to fix the traditional high-sugar, low nutritious breakfasts. Stay tuned for more innovations! 🚀
Private Investor - CFO
Apr 2023
PALTech is a MedTech project aiming at treating Type 2 diabetes. The project is led by 2 scientists: - Dr. Reginald Allouche: a renowned diabetologist who has been working on this disease for many years - Pr. Charles-Henri Malbert: MD and DMV, pHD, Senior Research Director, head of Aniscan research Unit (Rennes, France), Adjunct Professor of Medicine University of Adelaide, Full Member of National Medicine Academy
Show all 8 entries ↓
Investment activity
2020–2026 · 6 investments
20201202332024120261
Recent (last 2 years)Earlier